Declaration

PetDx and IDEXX expand access to Onco/K9, the cancer liquid biopsy test for Dogs

https://declarationpartners.com/wp-content/uploads/2022/02/Screenshot-2022-02-16-at-19.39.36.png

Declaration is proud to support PetDx as it successfully advances the adoption of its non-invasive canine oncology test, most recently in partnership with IDEXX Reference Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation.

https://www.linkedin.com/feed/update/urn:li:activity:6887496821208338432